• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄对宫颈癌根治性治疗的影响:基于大型全国队列的治疗模式和生存分析。

Impact of age on receipt of curative treatment for cervical cancer: an analysis of patterns of care and survival in a large, national cohort.

机构信息

Department of Radiation Oncology, University of Mississippi Medical Center, Jackson, MS, United States.

Department of Radiation Oncology, SUNY Downstate Medical Center, Brooklyn, New York, United States; Department of Veterans Affairs, NY, Harbor Healthcare System, Brooklyn, New York, United States.

出版信息

J Geriatr Oncol. 2019 May;10(3):465-474. doi: 10.1016/j.jgo.2018.10.005. Epub 2018 Oct 22.

DOI:10.1016/j.jgo.2018.10.005
PMID:30361099
Abstract

PURPOSE

Disparities in the receipt of standard of care based on age have been identified for several types of cancer including cervical cancer. The purpose of this study is to analyze patterns of care and survival for older patients receiving definitive treatment in a large, national cohort.

MATERIALS AND METHODS

The National Cancer Database was queried for patients with FIGO/AJCC IB2-IVA cervical cancer diagnosed from 2004 to 2014 who underwent definitive radiation or concurrent chemoradiation. Standard of care was defined as concurrent chemotherapy with external beam radiation and brachytherapy to a total dose ≥70 Gy. Multivariable logistic regression was used to determine factors associated with the receipt of standard of care. Multivariable Cox regression was used to determine covariables associated with differences in overall survival.

RESULTS

24,126 patients met inclusion criteria including 4052 women 61-70 years old, 2471 women 71-80 years old, and 1325 women over 80 years old. A smaller percentage of patients over age 60 received standard of care compared to younger aged patients. On multivariable analysis, older patients were less likely to be treated with standard of care. On multivariable Cox regression, ages 71-80 (HR 1.25, 95% CI-1.16-1.36, p < .001) and age > 80 (HR 1.90, 95% CI 1.73-2.07, P < .001) were associated with decreased overall survival. On subgroup analysis for patients with significant comorbidities, treatment with standard of care resulted in increased 5-year OS as compared to incomplete treatment.

CONCLUSIONS

Age was found to be an independent predictor for the receipt of standard of care treatment for cervical cancer.

摘要

目的

基于年龄的护理标准差距已在多种癌症中得到确认,包括宫颈癌。本研究的目的是分析大量全国性队列中接受确定性治疗的老年患者的护理模式和生存情况。

材料和方法

从 2004 年至 2014 年,国家癌症数据库对国际妇产科联盟/美国癌症联合委员会(FIGO/AJCC)IB2-IVA 期宫颈癌诊断为宫颈癌的患者进行了查询,这些患者接受了确定性放射治疗或同期放化疗。标准护理被定义为接受外部束辐射和近距离放射治疗,总剂量≥70Gy 的同时进行化疗。多变量逻辑回归用于确定与接受标准护理相关的因素。多变量 Cox 回归用于确定与总生存差异相关的协变量。

结果

24126 名患者符合纳入标准,其中 4052 名年龄在 61-70 岁的女性,2471 名年龄在 71-80 岁的女性,1325 名年龄在 80 岁以上的女性。年龄超过 60 岁的患者接受标准护理的比例低于年龄较小的患者。多变量分析显示,老年患者接受标准护理的可能性较小。多变量 Cox 回归分析显示,71-80 岁(HR 1.25,95%CI-1.16-1.36,p<0.001)和年龄>80 岁(HR 1.90,95%CI 1.73-2.07,p<0.001)与总生存时间缩短相关。对于患有显著合并症的患者亚组分析,与不完全治疗相比,标准治疗可提高 5 年 OS。

结论

年龄是宫颈癌患者接受标准护理治疗的独立预测因素。

相似文献

1
Impact of age on receipt of curative treatment for cervical cancer: an analysis of patterns of care and survival in a large, national cohort.年龄对宫颈癌根治性治疗的影响:基于大型全国队列的治疗模式和生存分析。
J Geriatr Oncol. 2019 May;10(3):465-474. doi: 10.1016/j.jgo.2018.10.005. Epub 2018 Oct 22.
2
Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.治疗中心和医院规模对局部晚期宫颈癌生存率的影响。
Gynecol Oncol. 2015 Dec;139(3):506-12. doi: 10.1016/j.ygyno.2015.07.015. Epub 2015 Jul 12.
3
Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database.术前放化疗联合子宫切除术治疗宫颈癌:大型医院数据库中的治疗模式和生存情况。
J Gynecol Oncol. 2019 May;30(3):e41. doi: 10.3802/jgo.2019.30.e41.
4
Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).日本宫颈癌患者采用大剂量率腔内近距离放疗(HDR-ICBT)联合每周 40mg/m²顺铂同期放化疗的可行性和急性毒性:多机构 2 期研究(JGOG1066)结果。
Int J Gynecol Cancer. 2012 Oct;22(8):1420-6. doi: 10.1097/IGC.0b013e3182647265.
5
Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic.根治性放化疗等待时间与局部晚期宫颈癌生存的相关性:在冠状病毒大流行期间的影响。
Gynecol Oncol. 2021 May;161(2):414-421. doi: 10.1016/j.ygyno.2021.02.026. Epub 2021 Mar 23.
6
Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?子宫颈鳞状细胞癌、腺癌和腺鳞癌女性患者的生存率真的存在差异吗?
Cancer. 1995 Nov 15;76(10 Suppl):1948-55. doi: 10.1002/1097-0142(19951115)76:10+<1948::aid-cncr2820761311>3.0.co;2-t.
7
Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.手术分期与临床分期在接受放化疗的国际妇产科联盟(FIGO)IIB-IVA期宫颈癌患者中的作用——德国放射肿瘤学组和妇科癌症组子宫-11多中心III期组间试验的急性毒性和治疗质量
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):243-53. doi: 10.1016/j.ijrobp.2015.10.027. Epub 2015 Oct 20.
8
Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.根治性子宫切除术及辅助放疗或放化疗治疗宫颈腺癌或腺鳞癌的临床行为和结局。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):420-7. doi: 10.1016/j.ijrobp.2011.12.013. Epub 2012 Feb 24.
9
RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.RTOG 0417:贝伐单抗联合根治性放疗及顺铂化疗治疗未经治疗的局部晚期宫颈癌患者的疗效。
Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):101-5. doi: 10.1016/j.ijrobp.2013.10.022.
10
Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.局部晚期宫颈癌患者先行根治性放化疗,随后行腔内脉冲剂量率图像引导自适应近距离放疗的临床疗效
Gynecol Oncol. 2015 Nov;139(2):288-94. doi: 10.1016/j.ygyno.2015.09.008. Epub 2015 Sep 11.

引用本文的文献

1
Dramatic Radiographic Response of Pelvis-Filling Locally Advanced Cervical Cancer Treated With Radiation and Chemotherapy.放疗联合化疗治疗的盆腔占位局部晚期宫颈癌的显著影像学反应
Cureus. 2024 Jun 2;16(6):e61544. doi: 10.7759/cureus.61544. eCollection 2024 Jun.
2
Evaluation and Prediction Analysis of 3- and 5-Year Relative Survival Rates of Patients with Cervical Cancer: A Model-Based Period Analysis.基于模型的时期分析:宫颈癌患者 3 年和 5 年相对生存率的评估和预测分析。
Cancer Control. 2024 Jan-Dec;31:10732748241232324. doi: 10.1177/10732748241232324.
3
Identification of age- and immune-related gene signatures for clinical outcome prediction in lung adenocarcinoma.
鉴定肺腺癌临床结局预测的年龄和免疫相关基因特征。
Cancer Med. 2023 Aug;12(16):17475-17490. doi: 10.1002/cam4.6330. Epub 2023 Jul 11.
4
Enhanced Recovery after Surgery and Endometrial Cancers: Results from an Initial Experience Focused on Elderly Patients.手术后加速康复与子宫内膜癌:以老年患者为重点的初步经验结果
Cancers (Basel). 2023 Jun 19;15(12):3244. doi: 10.3390/cancers15123244.
5
Patient, disease, and survival outcomes for stage IB to stage IV cervical cancer-A population study.IB 期至 IV 期宫颈癌的患者、疾病和生存结局:一项人群研究。
Womens Health (Lond). 2023 Jan-Dec;19:17455057231164551. doi: 10.1177/17455057231164551.
6
Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.局部晚期宫颈癌每次分次MRI引导下自适应近距离放疗的临床结果:单机构经验
Front Oncol. 2022 Mar 17;12:841980. doi: 10.3389/fonc.2022.841980. eCollection 2022.
7
To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study.年龄、分期和治疗在多大程度上影响浸润性宫颈癌患者的生存:一项基于人群的法国研究。
Cancer Causes Control. 2022 Mar;33(3):403-415. doi: 10.1007/s10552-021-01536-9. Epub 2022 Jan 26.
8
Characteristics and Treatments of Patients Aged 65 Years or Over with Cervical Cancer.65 岁及以上宫颈癌患者的特征和治疗方法。
Clin Interv Aging. 2020 Jun 3;15:841-851. doi: 10.2147/CIA.S255305. eCollection 2020.